Overview
Key stats
Fundamentals Sep 9- Open
- $200.48
- 52-wk high
- $258.69
- High
- $201.21
- 52-wk low
- $141.06
- Low
- $194.01
- Prev close
- $200.53
- Mkt cap
- $7.52B
- P/E
- 19.1x
- Volume
- 273.3K
- Fwd P/E
- 16.3x
- Beta
- 1.00
- Div yield
- 0.93%
- P/S
- 2.9x
- P/B
- 7.7x
- Profit margin
- +16.4%
- Op margin
- +24.2%
- ROE
- +32.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 14.9% below what analysts expected.
Earnings per share
$2.82 expected
What the street expects next
EPS expected
$2.88 to $3.06
Revenue expected
2 analysts
Last 30 days
Split both ways
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $617.4M | $641.1M | $644.8M | $663.2M |
| Cost of what it sold | $241.7M | $249.2M | $238.9M | $239.3M |
| Gross profit | $375.7M | $391.9M | $405.9M | $423.9M |
| What it spent | ||||
| Sales and admin | $85.9M | $89.6M | $84.0M | $98.5M |
| Other operating costs | $162.0M | $142.7M | $166.0M | $164.8M |
| Total operating expenses | $247.9M | $232.3M | $250.0M | $263.3M |
| What was left | ||||
| Operating profit | $127.8M | $159.6M | $155.9M | $160.6M |
| Interest on debt | $9.4M | $11.4M | $15.6M | $17.1M |
| Profit before tax | $123.0M | $151.5M | $141.7M | $147.0M |
| Tax | $31.4M | $36.4M | $34.6M | $38.3M |
| Net profit | $91.6M | $115.1M | $107.1M | $107.8M |
| EBITDA | $179.5M | $209.4M | $209.1M | $214.1M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
65 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is neutral
Tone of tracked coverage
Cannabis's MSO's Perfect Storm: Class Actions, RICO & Insurance Denials?
NeutralAug 24HIMS INVESTIGATION NOTICE: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm
NeutralAug 24Mobile Communications America Strengthens Arkansas Service Network with Acquisition of AVC Inc
NeutralAug 245 Undervalued Stocks to Rent Not Buy
NeutralAug 24